| Odds ratio (95% CI) | p value |
---|---|---|
Model 1 | ||
 Age, years | 1.06 (0.93–1.24) | 0.36 |
 Female sex | 0.73 (0.24–2.01) | 0.55 |
 Serum creatinine, mg/dL | 0.83 (0.66–0.99) | 0.040 |
 Initial PSL dose, mg/kg/day | 3.32 (0.29–41.66) | 0.34 |
 Concomitant cyclophosphamide use | 0.29 (0.09–0.87) | 0.027 |
Model 2 | ||
 Age, years | 1.08 (0.94–1.26) | 0.28 |
 Female sex | 0.76 (0.25–2.09) | 0.60 |
 Serum creatinine, mg/dL | 0.86 (0.70–1.02) | 0.09 |
 Initial PSL dose, mg/kg/day | 1.26 (0.13–14.65) | 0.85 |
 PSL dose at 12 months, mg/day | 1.14 (1.00–1.35) | 0.045 |